All lobbying filings
WILLIAMS AND JENSEN, PLLC
Lobbying for NOVOCURE INC. · Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors.
Filing
1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
New Hampshire
Lobbyists on this filing
4
-
JEANNE HAGGERTYPreviously held: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
-
ROBERT BUTORAPreviously held: Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
-
DANIEL ZIEGLER New on this filingPreviously held: Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson
-
JOSHUA DAVID FENDRICK New on this filingPreviously held: Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters
Government bodies contacted
2
Lobbying activity
2
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Foreign interests disclosed
2
-
NOVOCURE GMBHSwitzerland · 6340 Baar · owns 100% of the client · contributed $0.00
-
NOVOCURE LUXEMBOURG S.A.R.L. (OWNS 100% OF NOVOCURE GMBH)Luxembourg · L-1273, Luxemborg · owns 100% of the client · contributed $0.00